戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 sence or absence of monoclonal antibodies to adenylate cyclase toxin.
2 e, with the exception of the mutants lacking adenylate cyclase toxin.
3  depending on whether the bacteria expressed adenylate cyclase toxin.
4 e a primary in vivo target of the Bordetella adenylate cyclase toxin.
5 rains, but only in the absence of functional adenylate cyclase toxin, a B. pertussis toxin that has b
6 t advances in understanding the functions of adenylate cyclase toxin, a type 1 secretion system (T1SS
7                                              Adenylate cyclase toxin (ACT or CyaA) plays a crucial ro
8 ious studies indicate that B. bronchiseptica adenylate cyclase toxin (ACT) and the type III secretion
9                                              Adenylate cyclase toxin (ACT) has been shown to block ph
10 criptionally express cyaA, the gene encoding adenylate cyclase toxin (ACT) in other pathogenic Bordet
11                                              Adenylate cyclase toxin (ACT) is a critical factor in es
12                                          The adenylate cyclase toxin (ACT) is a multifunctional virul
13  with Bordetella pertussis, and the secreted adenylate cyclase toxin (ACT) is essential for the bacte
14                                          The adenylate cyclase toxin (ACT) of B. pertussis is a poten
15                                          The adenylate cyclase toxin (ACT) of Bordetella pertussis do
16                                          The adenylate cyclase toxin (ACT) of Bordetella pertussis in
17   B. pertussis uses pertussis toxin (PT) and adenylate cyclase toxin (ACT) to kill and modulate host
18 The catalytic domain of Bordetella pertussis adenylate cyclase toxin (ACT) translocates directly acro
19 ertussis and B. bronchiseptica, which encode adenylate cyclase toxin (ACT), are functionally intercha
20         Epinephrine and Bordetella pertussis adenylate cyclase toxin (ACT), cAMP-activating agents, a
21  filamentous hemagglutinin (FHA) and for the adenylate cyclase toxin (ACT), which blocks neutrophil f
22 l toxins, including pertussis toxin (PT) and adenylate cyclase toxin (ACT), which have both been show
23 ent of whooping cough, secretes and releases adenylate cyclase toxin (ACT), which is a protein bacter
24  another exotoxin produced by this pathogen, adenylate cyclase toxin (ACT).
25 of CD40 and IL-12 expression was mediated by adenylate cyclase toxin (ACT).
26      FITC-labeled bacteria had fivefold-less adenylate cyclase toxin activity than did unlabeled wild
27 ir function, we tested the effect of FITC on adenylate cyclase toxin activity, an important extracell
28 g bacteria, suggesting that FITC compromised adenylate cyclase toxin activity.
29                       This strain also lacks adenylate cyclase toxin, an essential virulence factor,
30 d Bvg-regulated virulence factors, including adenylate cyclase toxin and filamentous hemagglutinin, d
31 tachment of B. pertussis to neutrophils, but adenylate cyclase toxin blocks phagocytosis.
32     Monoclonal antibodies that recognize the adenylate cyclase toxin but fail to neutralize activity
33 ion of neutralizing monoclonal antibodies to adenylate cyclase toxin converted a serum that previousl
34 ding domain (RD) of the Bordetella pertussis adenylate cyclase toxin CyaA fused to the C terminus of
35  genetically detoxified Bordetella pertussis adenylate cyclase toxin (CyaA) as a delivery system for
36 ted Repeats in ToXins (RTX) leukotoxins, the adenylate cyclase toxin (CyaA) or alpha-hemolysin (HlyA)
37 everal virulence factors, among which is the adenylate cyclase toxin (CyaA) that plays a crucial role
38 cough agent Bordetella pertussis secretes an adenylate cyclase toxin (CyaA) that through its large ca
39 ordetella pertussis produces a cell-invasive adenylate cyclase toxin (CyaA) which is related to the R
40                       Here we found that the adenylate cyclase toxin (CyaA), a key virulence factor o
41 (ADs), like that of the Bordetella pertussis adenylate cyclase toxin (CyaA), are structures found in
42 overn the activities of Bordetella pertussis adenylate cyclase toxin (CyaA), Escherichia coli alpha-h
43 analysis showed that cyaA, the gene encoding adenylate cyclase toxin (CyaA), was the most downregulat
44       Both the wild-type strain RB50 and its adenylate cyclase toxin deletion (DeltacyaA) derivative
45 r lacking virulence factors-pertussis toxin, adenylate cyclase toxin, dermonecrotic toxin, filamentou
46  This allowed the engineering of recombinant adenylate cyclase toxin from Bordetella pertussis for th
47                               The Bordetella adenylate cyclase toxin-hemolysin (CyaA) and the alpha-h
48 peats-in-toxin (RTX) domain of the bacterial adenylate cyclase toxin-hemolysin (CyaA) is critical to
49                                          The adenylate cyclase toxin-hemolysin (CyaA) plays a key rol
50                                          The adenylate cyclase toxin-hemolysin (CyaA) plays a key rol
51                   These results suggest that adenylate cyclase toxin inhibits both Fc receptor-mediat
52                             About 70% of the adenylate cyclase toxin mutants were phagocytosed, but o
53 strains lacking filamentous hemagglutinin or adenylate cyclase toxin, nor when purified PT was admini
54                 In contrast, mutants lacking adenylate cyclase toxin were efficiently phagocytosed wh
55 ns deficient in filamentous hemagglutinin or adenylate cyclase toxin were incapable of proliferation
56 ine with the finding that antibodies against adenylate cyclase toxin were only elicited by BPZE1.CONC